Tear duct surgery is a procedure that creates a new drainage pathway for tears when the existing one becomes blocked or narrowed. The most common version, called dacryocystorhinostomy (DCR), has a success rate between 80% and 95%, making it one of the more reliable surgeries in ophthalmology. It’s typically performed when simpler treatments haven’t resolved persistent tearing, discharge, or recurring eye infections.
How Your Tear Drainage System Works
Your eyes constantly produce tear fluid to keep the surface moist and protected. That fluid needs somewhere to go. Each eyelid has a tiny opening near the inner corner of the eye called a punctum. These openings lead into small canals that travel about 8 to 10 mm through the eyelid tissue before merging into a shared channel. That channel empties into the lacrimal sac, a small pouch sitting between your eye and nose. From there, tears flow down through the nasolacrimal duct and exit underneath a structure inside your nose called the inferior turbinate.
A blockage can happen at any point along this pathway, but the nasolacrimal duct is the most common site. When tears can’t drain, they pool on the surface of your eye, causing constant watering, blurred vision, and sometimes sticky discharge. Stagnant fluid in the lacrimal sac can also become infected, leading to painful swelling near the inner corner of the eye.
When Surgery Becomes Necessary
Not every blocked tear duct needs surgery. In infants, the blockage often resolves on its own within the first year. For adults, treatment depends on the cause and severity. If warm compresses, gentle massage, or antibiotics for infection don’t clear things up, and the blockage keeps causing watery eyes or repeated infections, surgery becomes the standard next step. Some people with mild symptoms choose to live with the annoyance rather than pursue a procedure, and that’s a reasonable option when infection isn’t a recurring problem.
What Happens During the Procedure
The goal of DCR is straightforward: bypass the blocked section of the drainage system by creating a new opening between the lacrimal sac and the inside of your nose. This lets tears drain directly into the nasal cavity without needing to pass through the obstructed duct. Surgeons typically place a thin silicone stent through the new opening to keep it from closing while it heals. That stent stays in place for four to six months before being removed in a quick office visit.
There are two main approaches to this surgery, and each has trade-offs.
External DCR
The surgeon makes a small incision on the side of the nose, near the inner corner of the eye. This gives direct access to the lacrimal sac and allows the surgeon to create precise tissue flaps that are sutured together to form the new drainage channel. The advantage is excellent visibility during the operation, which contributes to its high success rates (around 93% to 95% in comparative studies). The downside is a small external scar, though it typically fades well over time. There’s also a slight risk of disrupting the muscles and tendons around the inner eyelid, which can occasionally affect the natural pumping action that moves tears toward the drainage system.
Endoscopic DCR
Instead of an external incision, the surgeon works entirely through the nostril using a thin camera called an endoscope. This leaves no visible scar and preserves the eyelid anatomy completely. Recovery tends to be faster: in one comparative study, symptom relief averaged 1.7 weeks for endoscopic patients versus 3.7 weeks for external. Patient satisfaction scores also tend to be higher because of the quicker bounce-back and absence of a scar. Success rates are comparable, generally ranging from 90% to 91%, though some studies have reported slightly lower numbers. The procedure does require specialized equipment and significant surgical skill with the endoscope, so availability can vary by center.
Success Rates and Risks
Both approaches work well. Across multiple studies, external DCR success rates land between 80% and 95%, and endoscopic DCR between 77% and 91%. The most common reason for “failure” is that the new opening gradually scars shut, causing tearing to return. This happens in roughly 5% to 10% of cases.
Beyond that, complications are uncommon. In a large review of external DCR outcomes, wound infection occurred in about 5% of patients, visible scarring that bothered the patient in about 9%, and small tissue growths (granulomas) at the surgical site in about 3%. Serious complications during the operation itself were essentially nonexistent in the same study. Bleeding and bruising around the eye are normal in the first few days and resolve on their own.
What Recovery Looks Like
Most people go home the same day. Expect some swelling and bruising around the inner corner of the eye and the side of the nose for the first week. You’ll apply antibiotic ointment to the incision area three times a day for about 10 days. If your eyes feel dry during this period, the same ointment can be placed inside the lower eyelid, though it will temporarily blur your vision.
The first week has the most restrictions. Avoid blowing your nose, since the surgical site connects to your nasal cavity and pressure could disrupt healing. Sleep with your head slightly elevated and try not to sleep on the side that was operated on. Don’t rub or pull at your eyelids near the surgical area.
For two weeks after surgery, skip strenuous exercise, heavy lifting, swimming, and hot tubs. Avoid bending over when possible. Sun exposure to the incision site should be minimized for a full month to help the scar heal with minimal visibility. You can return to most normal daily activities within a week or two, though you shouldn’t drive while taking prescription pain medication.
The silicone stent placed during surgery is barely noticeable. You might occasionally see a small loop of tubing near the inner corner of your eye, but it shouldn’t cause significant discomfort. Removal at the four-to-six-month mark is quick and usually painless, done in the office without anesthesia. In some cases where the new drainage channel needs extra support, the stent may be left in longer.
Results for Children vs. Adults
Blocked tear ducts are especially common in newborns, affecting up to 20% of infants. The blockage is usually at the very bottom of the nasolacrimal duct, where a thin membrane hasn’t fully opened. Most of these cases resolve by age one without intervention. When they don’t, a simpler office procedure called probing is typically tried first, where a thin wire is passed through the duct to open the obstruction. DCR surgery is reserved for children whose blockages persist after less invasive approaches have failed.
In adults, blockages tend to develop gradually from chronic inflammation, prior infections, or age-related narrowing of the duct. Women are affected more often than men. Because adult blockages rarely resolve on their own, the path to surgery tends to be more direct once conservative measures have been tried.